Teh Seng Pharmaceutical Mfg Co Ltd

As of June 30, 2026, Teh Seng Pharmaceutical Mfg Co Ltd carries a market capitalization of 2.02B, placing it among publicly traded companies globally. Its enterprise value stands at 1.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Teh Seng Pharmaceutical Mfg Co Ltd has 32.00M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Teh Seng Pharmaceutical Mfg Co Ltd maintains a current ratio of 2.10, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Teh Seng Pharmaceutical Mfg Co Ltd's stock has declined approximately 5.31% over the past 52 weeks. The 50-day moving average sits at 70.47, while the 200-day moving average is 68.01.

As of June 30, 2026, Teh Seng Pharmaceutical Mfg Co Ltd holds 331.59M in cash and equivalents against 160.53M in total debt, resulting in a net debt position of -171.06M. Total book value stands at 1.04B, with working capital of 340.40M providing operational flexibility.